| J9271 | Injection, pembrolizumab, 1 mg | 13,800 | $40 | $593.4K |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 2,440 | $40 | $85.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 870 | $90 | $77K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 480 | $130 | $62K |
| J0897 | Injection, denosumab, 1 mg | 2,160 | $20 | $41K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 260 | $90 | $22.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 250 | $90 | $22.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $60 | $18.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 17,250 | $1 | $17.3K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $160 | $5.5K |